Scintigraphy is the measurement and imaging of the radioactively labeled substances (radiopharmaceuticals) described above in the body using a gamma camera to visualize organ function. This takes the form of individual images (e.g., thyroid scintigraphy), whole-body images (e.g., skeletal scintigraphy), or serial (dynamic) images (e.g., renal scintigraphy). Scintigraphy can be used to test virtually all organ systems for metabolic function.
“SPECT” (single photon emission computed tomography), like radiological computed tomography (CT), provides cross-sectional imaging, i.e., slice-by-slice imaging of organ function in a volume; SPECT can also be combined with radiological computed tomography in the form of “SPECT/CT,” which allows better spatial mapping. Above all, so-called hybrid imaging – the combination of complementary imaging methods in one device (SPECT/CT, but also PET/CT) and thus also in one examination procedure – opens up completely new possibilities for diagnosis, treatment planning and therapy success monitoring;
this is particularly the case in cancer (PET/CT), but also in orthopedics (skeletal system), cardiology (heart attack risk assessment) and many other areas.”
None required.
The investigations consist of three phases:
In the preparatory phase, the radioactive substance is specifically prepared for each examination and then administered to the patient (usually intravenously).
The technical phase includes the performance of scintigraphy, SPECT, or PET measurements, including image evaluation. Subsequently, the information phase takes place (specialist evaluation).
These investigations are carried out by the Institute for Nuclear Medicine Hernals GmbH & CoKG.
No contrast agent will be administered.
Einige Krankenkassen erstatten Ihnen die Kosten einer Untersuchung zurück, diese wären:
SVA
KFA
BVA
